InvestorsHub Logo
Followers 53
Posts 7442
Boards Moderated 0
Alias Born 08/24/2010

Re: DaubersUP post# 233552

Sunday, 07/08/2018 3:45:18 PM

Sunday, July 08, 2018 3:45:18 PM

Post# of 403222
DaubersUP....I think the BD is for sure on B for OM, and it is by management design to maximize the value of the pipeline for the shareholders. I believe it is a vote of confidence by management on P trial meeting its end points with very nice statistical significance. And the company being able to save more of the P franchise for latter in the approval process. I think the company is very serious about being able to move forward on P under the 505[B][2] pathway for approval.

I am very excited about the B franchise but there is one problem that could lessen the potential of the drug, but that problem does not come into play,imo, in the OM designation. Notice i did not say the problem is impossible to solve. And of course, B will in all likelihood get the BTD designation from the FDA which will lead to reduced time to approval.

All the above JMO!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News